Literature DB >> 28228909

IgG4-related disease in an adolescent with radiologic-pathologic correlation.

Renato Cesar Ferreira da Silva1, Scott M Lieberman2, Henry T Hoffman3, Bruno Policeni1, Amani Bashir4, Richard J H Smith3, T Shawn Sato1.   

Abstract

Immunoglobulin G4-related disease (IgG4RD) is an immune-mediated condition characterized by lymphoplasmacytic infiltrates and fibrosis of affected organs. IgG4RD may affect many different organs either individually or together in a multiorgan condition and, thus, incorporates a wide range of fibroinflammatory phenotypes with shared pathologic features. Although IgG4RD most commonly occurs in late adulthood, it may affect children and adolescents. Only one case of IgG4RD presenting as isolated submandibular gland involvement has been reported in the pediatric population. Radiographic features of IgG4RD are often nonspecific making diagnosis challenging, but it is important for radiologists to be familiar with this diseased as its inclusion the differential for diffuse salivary enlargement may be the first step in making an accurate diagnosis. Here, we report a case of a child presenting with bilateral submandibular gland swelling to increase awareness of this condition in the pediatric population. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Entities:  

Year:  2016        PMID: 28228909      PMCID: PMC5310240          DOI: 10.1016/j.radcr.2016.10.008

Source DB:  PubMed          Journal:  Radiol Case Rep        ISSN: 1930-0433


Introduction

Chronic-sclerosing sialadenitis is an immune-mediated condition of the salivary glands that was first described in 1896 as isolated enlargement of the submandibular glands of adults and elderly patients and is often referred to as Küttner tumor. Although chronic-sclerosing sialadenitis has a clear predilection for the submandibular glands, it may involve the parotid glands, thus mimicking other causes of salivary gland enlargement such as Sjögren syndrome and Mikulicz disease. Sjögren syndrome is an autoimmune disease primarily affecting salivary and lacrimal glands. Mikulicz disease—a term that has fallen from contemporary use—was initially described in the 19th century to characterize idiopathic chronic enlargement of the submandibular, parotid, and lacrimal glands. Immunohistochemical technology to identify immunoglobulin (Ig) G4 molecules on plasma cells has permitted reclassification of a subgroup of salivary gland swelling cases previously considered idiopathic. IgG4 is a subclass of IgG usually found at low serum concentrations and, unlike other subclasses, is elevated in association with allergic reactions and autoimmune diseases rather than microbial infection [1]. High IgG4 titers can be found in various fibroinflammatory conditions such as bronchiectasis, primary sclerosing cholangitis, vasculitis, and the newly classified spectrum of diseases entitled IgG4-related disease (IgG4RD). Despite this association with various pathological processes, increased IgG4 levels are not thought to initiate inflammation or fibrosis but rather are believed to modulate chronic inflammation. Although knowledge regarding IgG4RD has increased over the last decade, diagnostic challenges remain. The variability of clinical presentation due to the wide range of potentially affected organs in IgG4RD makes the diagnosis difficult—sometimes taking years to establish [2]. This report is intended to increase awareness of IgG4RD as a process that may present as isolated submandibular gland swelling in a child.

Case report

A 16-year-old Hispanic male was referred to a regional hospital after bilateral neck masses were noted during a routine examination. The masses were first noted by the patient 2 months before his initial visit with slowly progressive enlargement thereafter. He denied fever, sweating, weight loss, and local phlogistic signs. Initial physical examination was unremarkable other than firm bilateral submandibular masses. Due to concern for possible bacterial infection, a course of antibiotics was prescribed but without improvement in submandibular gland swelling. Evaluations by otolaryngology and rheumatology confirmed the isolated submandibular gland enlargement. The neck was symmetric with enlargement of firm submandibular glands approximately 4 cm in diameter (Fig. 1). Initial diagnostic considerations included tuberculosis, Sjögren syndrome, and lymphoma. Computed tomography (CT) demonstrated homogenous enlargement of the bilateral submandibular glands without ductal dilation or ductal stones. Parotid and lacrimal glands were normal in appearance. No lymphadenopathy or thyroid abnormalities were appreciated (Fig. 2).
Fig. 1

Lateral (A and C) and frontal (B) views of the neck. No erythema or signs of acute infection of overlying skin, except for healing scar from surgical biopsy seen on picture (C).

Fig. 2

Contrast-enhanced neck CT. Axial (A) and coronal (B) images at the mandible plane shows homogenously enlarged bilateral submandibular gland without duct dilatation. There is no abnormal lymphadenopathy.

The initial pathologic analysis of open surgical biopsy of the left submandibular gland revealed a dense lymphocytic infiltrate composed of a mixture of B and T lymphocytes as shown by immunohistochemical staining with evidence of reactive secondary lymphoid follicle formation, consistent with a reactive inflammatory process without evidence of lymphoid neoplasia (Fig. 3A and B).
Fig. 3

H&E 4X. Salivary gland with dense lymphoplasmacytic infiltration and reactive lymphoid follicle formation (A). H&E 40X. Lymphoplasmacytic infiltrate with increased plasma cells, arrows (B). Immunostaining of submandibular gland biopsy showing IgG4+ plasma cells (C).

Abnormal laboratory results revealed low C3 (87 mg/dL; normal lower limit, 90 mg/dL) and elevated total IgG of 1885 mg/dL (normal upper limit, 1584 mg/dL). These findings may occur in inflammatory states such as with several autoimmune rheumatologic diseases. Low complements (such as C3) in children may reflect genetic deficiency, which can predispose to rheumatic disease, though in such cases, the levels of C3 are much lower than just below normal as noted here. Other blood tests were normal including Quantiferon gold TB test, urinalysis, renal and liver function, blood cell counts, hepatitis B and C tests, and inflammatory markers (erythrocyte sedimentation rate max of 10 mm/h, C reactive protein <.5 mg/dL). Autoantibodies (including SS-A, SS-B, antinuclear antibody, and rheumatoid factor) which may be positive in Sjögren syndrome or other rheumatologic diseases were all negative. Together, these findings suggested against lymphoma or tuberculosis as the underlying etiology. Although the histopathology was consistent with possible Sjögren syndrome and a minority of children with Sjögren syndrome may be negative for autoantibodies, the CT findings of normal parotid glands was highly atypical for childhood Sjögren syndrome. Because IgG4RD may present with isolated salivary gland swelling, further diagnostic evaluation specifically for IgG4RD was recommended. Immunostaining of the biopsy specimen revealed 365 IgG+ cells per high power field (hpf) and 266 IgG4+ cells/hpf, resulting in an IgG4+/IgG ratio of 72.8% (Fig. 3C). Quantitative serum IgG subclass analysis revealed markedly elevated IgG4 at 1050 mg/dL (normal upper limit 89 mg/dL) and elevated IgG2 at 874 mg/dL (normal upper limit 549 mg/dL), with IgG1 and IgG3 within reference range. These findings of markedly elevated IgG4+/IgG+ cell ratio within the gland as well as markedly elevated serum IgG4 confirmed the diagnosis of IgG4RD manifested by chronic sialadenitis. After diagnosis, oral prednisone therapy was started at 40 mg per day for 2 weeks with a subsequent tapering dose over the next 4 weeks. Submandibular gland swelling improved markedly with only subtle persistent swelling present at follow-up 1 year after discontinuation of prednisone. Throughout the course and at follow-up, no submandibular gland tenderness was noted, and no other organ manifestations developed.

Discussion

IgG4RD has gained attention due to identification of fibrosis in multiple organ sites associated with intense tissue infiltration by IgG4+ cells. Common involvement with IgG4+ infiltration has linked CCS along with other inflammatory conditions such as type 1 autoimmune pancreatitis and Reidel thyroiditis, which are all now considered part of the IgG4RD spectrum. [3] The differential diagnosis for IgG4-related sialadenitis includes infection (such as tuberculosis), lymphoma, Sjögren syndrome, sarcoidosis, and sialodocholithiasis. [4] The pathogenesis of IgG4RD remains uncertain but is thought to be linked to upregulation of genes involved in cell proliferation and extracellular matrix formation. [4] IgG4RD has become better recognized in adults (mean age, 53 years) in whom it mostly presents with symptoms involving the salivary and lacrimal glands, pancreas, and lymph nodes. [5], [6] Children and adolescents have not been included in larger IgG4RD studies and have been discussed mainly by case reports. In the pediatric population, pancreatic involvement was less common, whereas head and neck involvement continues to predominant, albeit with different organ distribution than adults. Most pediatric patients had orbital involvement, followed by sinonasal disease, lacrimal gland disease, and sialadenitis. [7] Other manifestations included disease of the mediastinum, retroperitoneum [8], pancreas, lung, and mesenterium. Histologic IgG4RD is suggested when at least one of the following is seen: dense lymphoplasmacytic infiltrate, storiform-type fibrosis, or obliterative phlebitis. Tissue immunostaining should reveal at least 10 IgG4+/hpf, but for lacrimal and salivary glands, a more expressive count of IgG4+ plasma cell per hpf is recommended (>100 IgG4+/hpf). In addition, tissue IgG4+/IgG+ ratio must be >40% in any circumstance. [9] Serum IgG4 is frequently elevated but can be normal in up to 50% of patients with active IgG4RD. [10] In our case, dense lymphoplasmacytic infiltrate was observed, with 266 IgG4+/hpf count, but other characteristic histologic features were absent. The combination of the patient’s clinical findings, serum IgG4 titer, tissue IgG4+/IgG ratio, and imaging studies demonstrates a pattern consistent with IgG4RD. [11] Radiological studies often reveal nonspecific findings such as diffuse organ enlargement, homogeneous contrast enhancement, and lymphadenopathy of 1–3 cm in diameter. [3], [12] Although the radiologic findings associated with IgG4-related disease may be nonspecific, it is important for radiologists to be familiar with this disease process to help raise suspicion for this difficult to diagnose disease. In the head and neck, the most common sites of involvement include the salivary glands, lacrimal glands, perineural involvement, lymph nodes, and the pituitary gland. Radiologists assume an important role by initially suggesting the disease, followed by further diagnostic investigation. [6] Fluorodeoxyglucose positron-emission tomography/computed tomography (PET/CT) is currently used to investigate subclinical and multiorgan disease for specific cases of IgG4RD, [13] in a similar process that allows IgG4-related pancreatitis to be diagnosed without tissue biopsy [14]. Treatment is still controversial, but corticosteroids are accepted as first-line therapy for IgG4RD, including pediatric population [7], with response rates generally beginning after 2 weeks of treatment. Recurrent salivary swelling has been reported at a rate of 24% after complete clinical remission [6] and tends to be higher among younger patients [15]. Longstanding periods without treatment may lead to irreversible fibrotic damage [3], [11]. In addition, IgG4RD has been associated with various types of malignancy, particularly in individuals with high-serum IgG4 titer, regardless of treatment with corticosteroids. [16]

Conclusion

IgG4RD is a systemic disease that can affect many different organs. Although the imaging features of IgG4RD can be nonspecific, radiologists play an important role in suggesting this disease, as patients respond well to corticosteroid therapy. Inclusion of IgG4RD in the differential of pediatric patients with bilateral homogenous salivary gland involvement can help avoid delayed diagnosis as well as avoid unnecessary procedures.
  16 in total

Review 1.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

2.  The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease.

Authors:  Hiroyuki Takahashi; Hiroyuki Yamashita; Miyako Morooka; Kazuo Kubota; Yuko Takahashi; Hiroshi Kaneko; Toshikazu Kano; Akio Mimori
Journal:  Joint Bone Spine       Date:  2014-02-22       Impact factor: 4.929

Review 3.  IgG4-related disease.

Authors:  Terumi Kamisawa; Yoh Zen; Shiv Pillai; John H Stone
Journal:  Lancet       Date:  2014-12-04       Impact factor: 79.321

4.  DNA microarray analysis of labial salivary glands in IgG4-related disease: comparison with Sjögren's syndrome.

Authors:  Hiroto Tsuboi; Yuji Nakai; Mana Iizuka; Hiromitsu Asashima; Chihiro Hagiya; Sayaka Tsuzuki; Tomoya Hirota; Haruka Miki; Shinya Hagiwara; Yuya Kondo; Akihiko Tanaka; Masafumi Moriyama; Isao Matsumoto; Seiji Nakamura; Toshio Yoshihara; Keiko Abe; Takayuki Sumida
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

5.  Idiopathic vs. secondary retroperitoneal fibrosis: a clinicopathological study of 12 cases, with emphasis to possible relationship to IgG4-related disease.

Authors:  Jan Laco; Miroslav Podhola; Kateřina Kamarádová; Ivo Novák; Daniel Dobeš; Miloš Broďák; Mária Hácová; Aleš Ryška
Journal:  Virchows Arch       Date:  2013-09-20       Impact factor: 4.064

6.  Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients.

Authors:  Wei Lin; Sha Lu; Hua Chen; Qingjun Wu; Yunyun Fei; Mengtao Li; Xuan Zhang; Xinping Tian; Wenjie Zheng; Xiaomei Leng; Dong Xu; Qian Wang; Min Shen; Li Wang; Jing Li; Di Wu; Lidan Zhao; Chanyuan Wu; Yunjiao Yang; Linyi Peng; Jiaxin Zhou; Yu Wang; Yue Sha; Xiaoming Huang; Yang Jiao; Xuejun Zeng; Qun Shi; Ping Li; Shulan Zhang; Chaojun Hu; Chuiwen Deng; Yongzhe Li; Shangzhu Zhang; Jinjing Liu; Jinmei Su; Yong Hou; Ying Jiang; Xin You; Haiting Zhang; Linyi Yan; Wen Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang; Peter E Lipsky
Journal:  Rheumatology (Oxford)       Date:  2015-06-22       Impact factor: 7.580

7.  [Comparative study of clinical features between unilateral and bilateral orbital IgG4-related disease].

Authors:  I Coloma-González; A Ceriotto; J Flores-Preciado; S Corredor-Casas; G Salcedo-Casillas
Journal:  Arch Soc Esp Oftalmol       Date:  2015-04-10

Review 8.  Immunoglobulin G4: an odd antibody.

Authors:  R C Aalberse; S O Stapel; J Schuurman; T Rispens
Journal:  Clin Exp Allergy       Date:  2009-02-13       Impact factor: 5.018

Review 9.  IgG4-related disease: a systematic review of this unrecognized disease in pediatrics.

Authors:  Faiz Karim; Jan Loeffen; Wichor Bramer; Lauren Westenberg; Rob Verdijk; Martin van Hagen; Jan van Laar
Journal:  Pediatr Rheumatol Online J       Date:  2016-03-25       Impact factor: 3.054

10.  IgG4-related disease: dataset of 235 consecutive patients.

Authors:  Dai Inoue; Kotaro Yoshida; Norihide Yoneda; Kumi Ozaki; Takashi Matsubara; Keiichi Nagai; Kenichirou Okumura; Fumihito Toshima; Jun Toyama; Tetsuya Minami; Osamu Matsui; Toshifumi Gabata; Yoh Zen
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.